Our flagship products—such as the CytoSpark® High-throughput Screening System, OMNIdrop System—empower scientists in antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, viral quantification, and biopharmaceutical quality control. Trusted by leading biotech and pharmaceutical companies, top-tier research institutions, and clinical laboratories worldwide, DPBIO is committed to advancing life sciences with high-performance analytical and detection systems.